LAWRENCE KWONG to Imidazoles
This is a "connection" page, showing publications LAWRENCE KWONG has written about Imidazoles.
Connection Strength
0.106
-
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma. J Clin Invest. 2015 Apr; 125(4):1459-70.
Score: 0.085
-
Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics. PLoS One. 2014; 9(7):e101286.
Score: 0.020